TYRA
Income statement / Annual
Last year (2025), Tyra Biosciences Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Tyra Biosciences Inc's net income was -$119.95 M.
See Tyra Biosciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$546.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$47.00 K
|
$8.00 K
|
| Gross Profit |
-$546.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$47.00 K
|
-$8.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$102.93 M
|
$80.08 M
|
$62.52 M
|
$43.01 M
|
$20.64 M
|
$7.20 M
|
$1.79 M
|
| General & Administrative Expenses |
$29.83 M
|
$24.10 M
|
$17.43 M
|
$15.92 M
|
$5.65 M
|
$2.09 M
|
$1.33 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$29.83 M
|
$24.10 M
|
$17.43 M
|
$15.92 M
|
$5.65 M
|
$2.09 M
|
$1.33 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$23.00 K
|
-$8.00 K
|
| Operating Expenses |
$132.76 M
|
$104.18 M
|
$79.95 M
|
$58.93 M
|
$26.29 M
|
$9.25 M
|
$3.12 M
|
| Cost And Expenses |
$132.76 M
|
$104.18 M
|
$79.95 M
|
$58.93 M
|
$26.29 M
|
$9.30 M
|
$3.12 M
|
| Interest Income |
$0.00
|
$17.70 M
|
$10.81 M
|
$3.65 M
|
$13.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.00 K
|
$1.00 K
|
| Depreciation & Amortization |
$546.00 K
|
$519.00 K
|
$357.00 K
|
$296.00 K
|
$140.00 K
|
$47.00 K
|
$8.00 K
|
| EBITDA |
-$119.40 M |
-$103.66 M |
-$79.59 M |
-$58.63 M |
-$26.15 M |
-$9.25 M |
-$3.11 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$12.82 M
|
$17.70 M
|
$10.81 M
|
$3.60 M
|
-$6.00 K
|
-$39.00 K
|
-$943.00 K
|
| Income Before Tax |
-$119.95 M
|
-$86.48 M
|
-$69.13 M
|
-$55.33 M
|
-$26.29 M
|
-$9.34 M
|
-$4.07 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$119.95 M
|
-$86.48 M
|
-$69.13 M
|
-$55.33 M
|
-$26.29 M
|
-$9.31 M
|
-$4.06 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.01 |
-1.51 |
-1.62 |
-1.23 |
-0.63 |
-0.22 |
-0.0954 |
| EPS Diluted |
-2.01 |
-1.51 |
-1.62 |
-1.23 |
-0.63 |
-0.22 |
-0.0954 |
| Weighted Average Shares Out |
$59.60 M
|
$57.22 M
|
$42.70 M
|
$41.88 M
|
$41.44 M
|
$42.54 M
|
$42.54 M
|
| Weighted Average Shares Out Diluted |
$59.60 M
|
$57.22 M
|
$42.70 M
|
$41.88 M
|
$41.44 M
|
$42.54 M
|
$42.54 M
|
| Link |
|
|
|
|
|
|
|
